- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00333749
The Effectiveness of Pasteurized Goat Milk in the Treatment of Childhood Oral Ulcer Diseases
September 3, 2009 updated by: HaEmek Medical Center, Israel
Phase 1 1 Study Assesing the Benefit of Pasteurized Goat Milk in Reducing Disease Severity of Young Children With Oral Ulcer Diseases
Children with acute diseases with oral ulcers (not included PRESENTATIONS OF SLE, IBD or IMMUNOCOMPRMIZED STATES)will receive several doses (drinking or mouth rinsing) of either pasteurized goat milk or cow milk.
Children will than be followed for length of the disease - signs and symptoms.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A prospective randomized controlled study that will include 110 previously health 6months - 5 years children (55 in each group) with acute oral ulcer disease (< 48 hours).
Children will receive several doses (drinking or mouth rinsing) of either pasteurized goat milk or cow milk.
Children will than be followed for length of the disease - sings and symptoms by questioner to parents, and physical examination by there physicians. .
Study Type
Interventional
Enrollment (Actual)
65
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Afula, Israel, 18101
- Dan Miron
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months to 5 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > 6 months or < 5 years.
- Acute (< 48 hours) oral ulcer disease.
- > 5 ulcers.
- Cooperative parents .
- Signing inform consent.
Exclusion Criteria:
- All types of immunosuppression, IBD, SLE, recurrent oral ulcer, disease > 48 hours, age , 6 < months or > 5 years.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
55 children < 5 years with acute oral ulcer disease.
|
|
|
Placebo Comparator: 2
55 Children < 5 years with acute oral ulcer disease.
|
Drinking or rinsing the mouth 2-3 times for one day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Severity of disease
Time Frame: 3 years
|
3 years
|
|
Length of disease
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dan Miron, MD, HaEmek Medicak Center, Afula, Israel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2006
Primary Completion (Actual)
December 1, 2007
Study Completion (Actual)
December 1, 2007
Study Registration Dates
First Submitted
January 13, 2006
First Submitted That Met QC Criteria
June 5, 2006
First Posted (Estimate)
June 6, 2006
Study Record Updates
Last Update Posted (Estimate)
September 4, 2009
Last Update Submitted That Met QC Criteria
September 3, 2009
Last Verified
September 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3870505
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.